Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 crossover pharmacokinetic studies of S-600918 with cyclosporine, midazolam, and food effect in healthy adults
jRCT2031200413Phase 1Completed
- Sponsor
- Shionogi & Co., Ltd.
- Start
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of sivopixant in refractory chronic cough (RCC) (3 arms), sponsored by Shionogi & Co., Ltd. Primary endpoints: Cmax, Tmax and 6 more. Started Mar 2021; status: completed.
02
Drugs
sivopixant
03
Conditions
refractory chronic cough (RCC)
Beyond the preview
Go deeper on jRCT2031200413.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031200413.